Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2169 - 2176 of 11455 results
About Face: Laboratory-Developed Tests for COVID-19 Now Subject to EUA Requirements
November 19, 2021| Blog| Viewpoint
Mintz Lawyer’s New Book Puts 11 Faces on America’s Immigration ‘Crisis’
November 19, 2021| News
OSHA Vaccine Rule Blocked Permanently by Fifth Circuit, But Judicial Review Will Continue
November 19, 2021| Blog| Viewpoint
New York Significantly Expands its Whistleblower Law
November 19, 2021| Blog| Viewpoint
Examining Art Units to Avoid Subject Matter Eligibility Challenges for Bioinformatics and AI-related Patents
November 18, 2021| Blog| Viewpoint
The End Is (Somewhat) Nigh: FDA Begins Rolling Back Enforcement Policies Implemented in Response to the COVID-19 Pandemic
November 16, 2021| Blog| Viewpoint
Journeys from There to Here (The Middle Way)
November 16, 2021| News
Should Employers Keep Preparing for the COVID-19 ETS?
November 16, 2021| News
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Defending AI, Machine Learning Patents In Life Sciences
October 1, 2024
Intellectual Property Chair Michael Renaud and Associates Meena Seralathan, Simone Yhap, and Williams Dixon recently wrote an article for Law360 focused on protecting artificial intelligence and machine learning patents in the life sciences industry following the US Supreme Court’s 2014 decision in Alice v. CLS Bank.